Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

114.23 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,850
Open 114.23
Bid (Size) 114.23 (1)
Ask (Size) 114.90 (1)
Prev. Close 114.23
Today's Range 114.23 - 114.23
52wk Range 72.43 - 119.96
Shares Outstanding 1,253,809,440
Dividend Yield 2.77%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Gilead Sciences Stock Slipped Today
Changes in a federal healthcare authority could negatively impact one of the company's important businesses. 
Via The Motley Fool
BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive
The Supreme Court's Braidwood decision only concretized the power of the Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting... 
Via Stocktwits

Performance

YTD
+24.3%
+24.3%
1 Month
+3.0%
+3.0%
3 Month
+9.6%
+9.6%
6 Month
+21.7%
+21.7%
1 Year
+47.0%
+47.0%

More News

Read More
Visa, Disney, Blackstone And A Health Care Stock On CNBC's 'Final Trades'
Via Benzinga
Why Gilead Sciences (GILD) Stock Is Up Today
Via StockStory
Topics Stocks World Trade
Price Over Earnings Overview: Gilead Sciences
Via Benzinga
Why Gilead Sciences Stock Just Popped
Via The Motley Fool
Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
Via Benzinga
This Gilead Sciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet
Via Stocktwits
Topics Workforce
Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
From Gilead Sciences, Inc.
Via Business Wire
1 Value Stock Worth Your Attention and 2 Facing Headwinds
Via StockStory
Topics Supply Chain
Director Sells 11,136 Shares of SRRK, a Stock Up 330% in Past Year
Via The Motley Fool
Topics Regulatory Compliance
Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know
Via StockStory
Topics Stocks World Trade
NAFA Publishes New Fleet Safety Guidebook Aimed  at Developing Safety-First Culture in all Organizations
Via News Direct
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
From Pomerantz LLP
Via GlobeNewswire
2 Large-Cap Stocks to Consider Right Now and 1 That Underwhelm
Via StockStory
Topics Supply Chain
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
From Pomerantz LLP
Via GlobeNewswire
Expanding the Preventive Care Frontier: Dr. Reddy’s Launches Sanofi’s Beyfortus® in India
Via AB Newswire
Topics Death
Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment
Via StockStory
Topics Artificial Intelligence
Which S&P500 stocks are gapping on Tuesday?
Via Chartmill
GILD Investors Have Opportunity to Join Gilead Sciences, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gilead Sciences, Inc. - GILD
From Pomerantz LLP
Via GlobeNewswire
Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025
From Gilead Sciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 114.23
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 07/29/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 143.22B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 143B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.